NeuroOne Medical Technologies (OTC:NMTC) announced that it was approved to uplist and begin trading on the Nasdaq market. Eden Prairie, Minn.-based NeuroOne expects trading to commence today at the open of the market, with the company trading under the “NMTC” ticker, according to a news release. The developer of surgical care options for patients suffering […]
Bioelectronic Medicine
FDA issues draft clinical trial guidelines for neurostim, other devices to treat diabetes
The FDA today issued a draft guidance with recommendations for clinical trials for certain devices intended for treating diabetes. Included in the guidance are recommendations for feasibility and early feasibility clinical studies for certain medical devices intended to therapeutically improve glycemic control in patients with type 2 diabetes mellitus, independent of medication delivery, according to […]
Neurostimulation may help restore arm function years after stroke
Stroke survivors who received vagus nerve stimulation (VNS) combined with rehabilitation had better arm and hand function, according to the results of a new study. In the international, multi-center clinical trial, 53 participants with moderate to severe arm weakness nine months to 10 years post-stroke received rehabilitation paired with VNS. Fifty-five patients within the same […]
Theranica lands VA contract for migraine device
Theranica announced today that it has signed a contract to supply its Nerivio device to the U.S. Department of Veterans Affairs (VA) for use by veterans who suffer from chronic migraine headaches. Nerivio is worn on the upper arm for 45 minutes and uses remote electrical neuromodulation to activate the brain’s native conditioned pain modulation […]
FDA authorizes marketing of device to boost tongue muscles and reduce sleep apnea
The FDA announced today that it authorized the marketing of a device for reducing snoring and mild obstructive sleep apnea. The prescription-only device is used while awake to improve tongue muscle function, which can help prevent the tongue from collapsing backward and obstructing the airway during sleep. It is the first device of this kind […]
FDA approves Boston Scientific Vercise Genus deep brain stimulation system
Boston Scientific (NYSE:BSX) announced today that it received FDA approval for its fourth-generation Vercise Genus DBS system. Marlborough, Mass.-based Boston Scientific’s Vercise Genus deep brain stimulation (DBS) system portfolio is approved for conditional use in a magnetic resonance imaging (MRI) environment. It features a family of Bluetooth-enabled, rechargeable and non-rechargeable implantable pulse generators capable of powering […]
NeuroOne Medical appoints new CFO
NeuroOne Medical Technologies (OTC:NMTC) announced today that it appointed Ronald McClurg as its chief financial officer. McClurg, a veteran of 30 years in the space of financial leadership, has held the role of CFO for companies including Orthomet, Incisive Surgical, Video Sentry and Insignia Systems, having begun his career in public accounting at Ernst and […]
Nesos raises $16.5M
“Brain-hacking” wireless earbud-like technology developing startup Nesos reportedly raised $16.5 million earlier this month. Reuters reported on Dec. 10 that the San Francisco-based startup’s CEO, Konstantinos Alataris, described its technology as designed to “hack” the brain, using electric fields to make changes through the device, which bears resemblance to a pair of wireless earbuds. The […]
Spark Biomedical wins FDA breakthrough nod for newborn opioid withdrawal relief device
Spark Biomedical announced today that the FDA granted breakthrough device designation to its transcutaneous electrical nerve stimulator designed to reduce signs and symptoms of neonatal opioid withdrawal syndrome (NOWS). NOWS results from exposure to prescription or non-prescription opioids such as methadone or heroin during pregnancy. Currently, no nationwide standard of care exists for managing NOWS, although […]
CarThera collects $14.3M
CarThera announced today that it received a $2.3 million (€2 million) grant and $12 million (€10.5 million) in equity, totaling $14.3 million. Paris-based CarThera was selected by the EIC Accelerator Pilot to receive the funds as it develops its Domeus project for treating glioblastoma patients. In addition to the money, CarThera is also slated to […]
Boston Scientific launches Vercise Genus DBS system in Europe
Boston Scientific (NYSE:BSX) announced that it received CE Mark for its fourth-generation Vercise Genus deep brian stimulation system. Vercise Genus includes full-body MRI conditional and Bluetooth capabilities within a DBS system designed for treating the symptoms of Parkinson’s disease, essential tremor and dystonia by delivering electrical stimulation to targeted parts of the brain. Marlborough, Mass.-based Boston […]
